|
Encorafenib, binimetinib, and cetuximab in BRAF V600E–mutated colorectal cancer: an early post-marketing phase vigilance study |
|
|
|
Titel: |
Encorafenib, binimetinib, and cetuximab in BRAF V600E–mutated colorectal cancer: an early post-marketing phase vigilance study |
Auteur: |
Sakata, Hidenori Murase, Maki Kato, Takeshi Yamaguchi, Kensei Sugihara, Kenichi Suzuki, Shigenobu Yoshino, Takayuki |
Verschenen in: |
International journal of clinical oncology |
Paginering: |
Jaargang 28 () nr. 1 pagina's 139-144 |
Jaar: |
2022-11-10 |
Inhoud: |
|
Uitgever: |
Springer Nature Singapore, Singapore |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|